Back to Markets
PRPraxis Precision Medicines Inc

Praxis Precision Medicines Inc

PRAXNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$349.97

-2.660000 (-0.75%)

As of 05/29/26 EDT · USD

Compare
Low: $37.19Current: $349.97High: $366.52

Key Statistics

Open

$352.63

Day High

$355.00

Day Low

$338.07

Prev. Close

$352.63

VolumeShares traded today.

361.94K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$9.76B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-26.18

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$366.52

52W LowLowest price over the past 52 weeks.

$37.19

50D MAAverage closing price over the last 50 trading days.

$326.64

200D MAAverage closing price over the last 200 trading days.

$229.96

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-0.2%

1M

+8.3%

6M

+89.9%

YTD

+22.2%

1Y

+807.8%

About

Ulixacaltamide is an investigational new drug developed by Praxis Precision Medicines for the treatment of essential tremor (ET). It is a small molecule designed to selectively inhibit T-type calcium channels, reducing the abnormal neuronal burst firing in the cerebello-thalamo-cortical (CTC) circuit that is believed to cause tremors.

praxismedicines.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade PRAX

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.